ALLBETTERNOW!
Well-known member
Still a long way to go but a nice leap for valve in valve TAVR. If they can get the morbidity numbers down or close to OHS then I think it becomes the standard of care. Remember Medtronic's is out there pushing their product too
http://www.edwards.com/ns20151015-2
http://www.kcentv.com/story/30271301...lve-procedures[/URL
1-Year Outcomes from PARTNER II Valve-in-Valve Study Demonstrate High Survival, Low Stroke Rate
IRVINE, Calif., Oct. 15, 2015 /PRNewswire/ -- Edwards Lifesciences Corporation (NYSE: EW), the global leader in the science of heart valves and hemodynamic monitoring, today announced it has received U.S. Food and Drug Administration (FDA) approval for aortic valve-in-valve procedures using the Edwards SAPIEN XT transcatheter heart valve.
"We were very pleased to see 100 percent survival at 30 days with the 100 high-risk patients treated with the SAPIEN XT valve-in-valve procedure in the continued access registry," said Danny Dvir, M.D., interventional cardiologist at the Center for Heart Valve Innovation at St. Paul's Hospital, Vancouver, who presented the data. "This is quite remarkable and supports transcatheter aortic valve-in-valve replacement with the SAPIEN XT valve as a safe therapeutic alternative to reoperation for patients in need of a subsequent tissue valve replacement."
Now us " young" people just need them to get working on valve in a valve in a valve...... Or a 2nd valve that will go 25+
http://www.edwards.com/ns20151015-2
http://www.kcentv.com/story/30271301...lve-procedures[/URL
1-Year Outcomes from PARTNER II Valve-in-Valve Study Demonstrate High Survival, Low Stroke Rate
IRVINE, Calif., Oct. 15, 2015 /PRNewswire/ -- Edwards Lifesciences Corporation (NYSE: EW), the global leader in the science of heart valves and hemodynamic monitoring, today announced it has received U.S. Food and Drug Administration (FDA) approval for aortic valve-in-valve procedures using the Edwards SAPIEN XT transcatheter heart valve.
"We were very pleased to see 100 percent survival at 30 days with the 100 high-risk patients treated with the SAPIEN XT valve-in-valve procedure in the continued access registry," said Danny Dvir, M.D., interventional cardiologist at the Center for Heart Valve Innovation at St. Paul's Hospital, Vancouver, who presented the data. "This is quite remarkable and supports transcatheter aortic valve-in-valve replacement with the SAPIEN XT valve as a safe therapeutic alternative to reoperation for patients in need of a subsequent tissue valve replacement."
Now us " young" people just need them to get working on valve in a valve in a valve...... Or a 2nd valve that will go 25+